Antidiabetic agent englitazone enhances insulin action in nondiabetic rats without producing hypoglycemia

This publication has 15 references indexed in Scilit:

• Actions of novel antidiabetic agent englitazone in hyperglycemic hyperinsulinemic ob/ob mice
  Diabetes, 1990
• Oral Hypoglycemic Agents
  New England Journal of Medicine, 1989
• Symptomatic Hypoglycemia in NIDDM Patients Treated With Oral Hypoglycemic Agents
  Diabetes Care, 1989
• Sulphonylureas and hypoglycaemia
  BMJ, 1988
• A new potentiator of insulin action
  FEBS Letters, 1983
• Ciglitazone, a new hypoglycemic agent. I. Studies in ob/ob and db/db mice, diabetic Chinese hamsters, and normal and streptozotocin-diabetic rats
  Diabetes, 1983
• Reduction of insulin resistance in obese and/or diabetic animals by 5-[4-(1-methylcyclohexylmethoxy)benzyl]-thiazolidine-2,4-dione (ADD-3878, U-63,287, ciglitazone), a new antidiabetic agent
  Diabetes, 1983
• Ciglitazone, a new hypoglycemic agent. II. Effect on glucose and lipid metabolisms and insulin binding in the adipose tissue of C57BL/6J-ob/ob and -+/? mice
  Diabetes, 1983
• Insulin resistance, insulin insensitivity, and insulin unresponsiveness: A necessary distinction
  Metabolism, 1978
• Inhibition of glucose transport in the human erythrocyte by cytochalasin B
  Biochemistry, 1973